🔴 Surgepays is trading 5.1% down today on continued dilution concerns from its public offering

Surgepays is trading 5.1% down today at $0.31, extending a sharp slide following the announcement of an underwritten public offering of common stock and pre-funded warrants.

• The stock's decline is primarily driven by investor concerns over share dilution resulting from the recent capital raise.
• With no fresh catalysts reported on July 16, 2026, the ongoing weakness reflects a broader risk-off market sentiment and the continued digestion of the new supply of shares.